Patient and Physician Intervention to Increase Organ Donation

NCT01697137 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 916

Last updated 2015-02-23

No results posted yet for this study

Summary

The number of persons on the national solid organ waiting list continues to increase while the number of donated organs has failed to keep pace. In some portions of northeastern Ohio the donation rate is as low as 32%. There is a positive association between discussing organ donation with a primary care physician and signing a donor card. However, such discussions are rare. The investigators propose a blinded randomized controlled trial to evaluate the effectiveness of two interventions: 1) showing a donation video to patients in primary care settings waiting to see their physician and 2) cueing of primary care providers to have donation discussions with their patients. The study will be conducted throughout Cuyahoga County in at least 10 ambulatory clinics associated with a single county medical system. Nine hundred patients over 15.5 years of age will be enrolled. The investigators hypothesize that patients exposed to the interventions will be 1) more likely to consent to donate organs, 2) more likely to have donation discussions with their primary care providers, and 3) equally satisfied with the time spent with their doctor compared to patients who are not exposed to the interventions.

Conditions

  • Tissue and Organ Donation
  • Communication

Interventions

BEHAVIORAL

Participant Video and Provider Cueing

Participants will watch a 5-minute video and then select a question about donation to discuss with their primary care provider (provider cueing).

Sponsors & Collaborators

  • Case Western Reserve University

    lead OTHER

Principal Investigators

  • John D Thornton, MD, MPH · Case Western Reserve University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
78 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01697137 on ClinicalTrials.gov